7Baggers
 Sellas Life Sciences Reports Q3 2025 Financial Results  TipRanks Thu, 13 Nov 2025 05:02:47 GMT
 SELLAS Life Sciences Narrows Losses And Advances Cancer Trials  Finimize Wed, 12 Nov 2025 23:36:33 GMT
 SELLAS Life Sciences Q3 net loss narrows to $6.8 mln  MarketScreener Wed, 12 Nov 2025 21:35:36 GMT
 why is sellas life sciences stock falling today?  MSN Wed, 05 Nov 2025 01:52:58 GMT
 Why Is SELLAS Life Sciences Stock Falling Today?  MSN Thu, 30 Oct 2025 11:33:14 GMT
 transcript : sellas life sciences group, inc. - special call  MarketScreener Wed, 29 Oct 2025 21:20:35 GMT

SELLAS Life Sciences Group, Inc
(NASDAQ:SLS) 

SLS stock logo

SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a wilms tumor 1 targeting peptide-based cancer immun...

Full Time Employees: 5
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends